cagrilintide combined with retatrutide RetaCagri Reconstitution: Pre-Mixed & Separate Vial Math (2026) Retatrutide 12.5mg + Cagrilintide 2.5mg

The options may be chosen on the product page Select options This product has multiple variants

Many findings are from cell/ex vivo/animal models

Treatment length: Usually between 2 to 4 weeks, followed by medical evaluation

Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

In laboratory settings, Dihexa has been studied for its relationship to cell signaling pathways, receptor interaction, synaptic architecture, and neurobiological communication systems in non-human experimental models

doi: 10.3390/nu14153101 122